HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Srinivas Ramishetti Selected Research

Immunotherapy

4/2022Dual-Targeted Lipid Nanotherapeutic Boost for Chemo-Immunotherapy of Cancer.
11/2020Investigation of pH-Responsiveness inside Lipid Nanoparticles for Parenteral mRNA Application Using Small-Angle X-ray Scattering.
11/2013Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Srinivas Ramishetti Research Topics

Disease

15Neoplasms (Cancer)
04/2022 - 02/2012
3Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2020
2Colitis
01/2021 - 11/2019
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2019 - 10/2018
2Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 01/2016
2Melanoma (Melanoma, Malignant)
11/2013 - 02/2012
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2021
1COVID-19
01/2021
1Infections
01/2021
1Liver Diseases (Liver Disease)
11/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2016
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2016
1Virus Diseases (Viral Diseases)
07/2015
1Inflammation (Inflammations)
07/2015
1Lung Neoplasms (Lung Cancer)
06/2015
1Glioma (Gliomas)
02/2015
1Neoplasm Metastasis (Metastasis)
11/2013
1Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2012

Drug/Important Bio-Agent (IBA)

5Lipid NanoparticlesIBA
04/2022 - 11/2020
5LipidsIBA
04/2022 - 02/2012
3Pharmaceutical PreparationsIBA
01/2022 - 04/2013
2Small Interfering RNA (siRNA)IBA
10/2021 - 01/2016
2RNA (Ribonucleic Acid)IBA
10/2021 - 11/2020
2VaccinesIBA
01/2021 - 02/2012
2Messenger RNA (mRNA)IBA
11/2020 - 11/2019
2Proteins (Proteins, Gene)FDA Link
11/2019 - 10/2018
2AntigensIBA
11/2013 - 02/2012
2peptide SVYDFFVWLIBA
11/2013 - 02/2012
1Heme Oxygenase-1IBA
04/2022
1Immune Checkpoint InhibitorsIBA
04/2022
1AntibodiesIBA
10/2021
1ErbB Receptors (EGF Receptor)IBA
10/2021
1InterferonsIBA
01/2021
1mRNA VaccinesIBA
01/2021
1Peptide Initiation Factors (Initiation Factor)IBA
01/2021
1IntegrinsIBA
01/2021
1Antisense OligonucleotidesIBA
01/2020
1Therapeutic UsesIBA
11/2019
1Chimeric Antigen ReceptorsIBA
01/2019
1Cyclin D1IBA
01/2016
1Drug CarriersIBA
06/2015
1Hyaluronic Acid (Hyaluronan)IBA
02/2015
1Peptides (Polypeptides)IBA
11/2013
1Protein Subunit VaccinesIBA
11/2013
1AutoantigensIBA
11/2013
1Cytotoxins (Cytolysins)IBA
09/2013
1Antiviral Agents (Antivirals)IBA
09/2013
1calcium phosphateIBA
09/2013
1Succinic Acid (Succinate)IBA
04/2013
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
04/2013
1Fluorouracil (Carac)FDA LinkGeneric
04/2013
1polyethylene glycol 1000IBA
04/2013
1Paclitaxel (Taxol)FDA LinkGeneric
04/2013
1tocophersolanIBA
04/2013
11,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA
02/2012

Therapy/Procedure

10Therapeutics
04/2022 - 12/2012
3Immunotherapy
04/2022 - 11/2013
2Drug Therapy (Chemotherapy)
04/2022 - 04/2013
1Intraperitoneal Injections
11/2020
1Immunomodulation
11/2019
1RNAi Therapeutics
02/2015